To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...
Blue Earth Therapeutics today announced that the first patients in the UK have been administered with the investigational ...
Ernie Strauss and Ronald Wakefield, who met through the patient navigation program of Northside Hospital, have built a ...
DelveInsight's Castration-sensitive Prostate Cancer Market Insights report includes a comprehensive understanding of current treatment practices, CSPC emerging drugs, market share of individual ...
Foresee Pharmaceuticals has shown that a long-acting version of its injectable prostate cancer med Camcevi can help patients ...
Abstract: Deep learning models for prostate cancer diagnosis are often hindered by the scarcity and imbalance of medical imaging datasets. This study addresses this challenge by developing a Deep ...
A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback